Group-based ACT for psychological distress in young people
Official title: Group-based ACT for Psychological Distress of Young People
Run by Sorlandet Hospital HF · NCT07617467 · Data updated 2026-11-12
Researchers are testing whether group-based ACT helps 16-25 year olds with depression or anxiety more than the usual individual therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 25 Years |
| Sex | All |
| Enrollment | 212 (estimated) |
| Sponsor | Sorlandet Hospital HF Government |
| Locations | 2 sites (Arendal, Agder and 1 other locations) |
| Status | Recruiting |
| Started | March 9, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT07617467 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16-25 with symptoms of depression or anxiety and meeting inclusion criteria, including a DASS-21 depression score of 14 or lower.
✕Probably not a fit
Some participants may not experience benefit and may continue to have symptoms or require alternative treatments.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares group-based Acceptance and Commitment Therapy (ACT) to treatment as usual (TAU) in adolescents and young adults with symptoms of depression and/or anxiety. Participants are randomly assigned to either the ACT group format or standard individual psychotherapy. The ACT program focuses on flexibility, accepting inner experiences, and acting in line with personal values. The study aims to see if the group format can provide similar or better outcomes while potentially increasing access to care.
Why it matters
Potential benefit: If successful, participants and others could experience improved mood, reduced anxiety, and easier access to effective therapy.
How similar studies have gone: Previous research suggests ACT is beneficial for anxiety and depression, but this trial adds evidence in a group-format for youth; results will clarify effectiveness and scalability.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Score on DASS-21 depression scale ≤ 14 Exclusion Criteria: * Psychosis
Where it's running
-
Sørlandet Hospital
Arendal, Agder, Norway Recruiting -
Sorlandet hospital
Kristiansand, Agder, Norway Recruiting
Study contacts
- Study coordinator: Vegard Øksendal Haaland, PhD
- Email: vegard.oksendal.haaland@sshf.no
- Phone: 40454145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Mobile CBT for mood after a stroke
A mobile CBT app called Maya is tested to see if it helps adults recently recovering from stroke manage depression and anxiety during rehab.
-
How controlled sounds and sensory stimulation affect the brain in an acoustic chamber
This project will test how controlled sensory stimulation, such as music, changes brain activity and behavior in adults with epilepsy and in healthy volunteers.
-
Online group I-Reconstruction psychotherapy to reduce anxiety
This trial tests whether a 10-week online group course using the I-Reconstruction method can help adults with anxiety feel less anxious.
-
Behavioral health collaborative care for family members of ICU survivors in the Post-ICU clinic pilot
This pilot tests a telehealth-based behavioral health program using the NeuroFlow app for family members of ICU survivors to try to reduce anxiety, depression, and PTSD symptoms.
-
No Time to Wait — Single-Session Growth-Mindset Program for Teens
This project will try a single-session online growth-mindset program to help Hong Kong adolescents aged 12–17 who have elevated depression or anxiety symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.